Analysts/Institutional Investor Meet/Con. Call Updates

AI summary - Q2FY27 consolidated operating revenue grew 35% to ₹2,178 Cr; PAT grew 43% to ₹192 Cr with margin improving to 9% - Insurance premium grew 38% YoY to ₹9,385 Cr; core online new health and term grew 42% YoY - IRDAI consultation paper aims to reduce mis-selling and improve claims; Policybazaar supports and will comply fully - Cost discipline emphasized amid tougher demand; growth remains critical with focus on scale and customer proposition - PB Partners, UAE business, and PB for Business revenue up 40%, nearing break-even - AI investments improving efficiency, lead conversion, and cost control over next 12-18 months - PB Health progressing on plan; revenue run rate expected ₹40-45 Cr/month by March 2027 - POSP business uncertain under new regulations; awaiting final rules for clarity - Management committed to growth, customer service, and regulatory alignment over next 1000 days